KBC Group NV Has $177.50 Million Holdings in Intuitive Surgical, Inc. $ISRG

Posted by Francis Steltz on Jul 20th, 2026

KBC Group NV cut its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 8.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 385,028 shares of the medical equipment provider’s stock after selling 35,565 shares during the period. KBC Group NV’s holdings in Intuitive Surgical were worth $177,495,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Norges Bank purchased a new position in Intuitive Surgical during the 4th quarter worth approximately $2,856,987,000. J. Stern & Co. LLP lifted its holdings in shares of Intuitive Surgical by 18,504.6% in the fourth quarter. J. Stern & Co. LLP now owns 2,127,248 shares of the medical equipment provider’s stock valued at $1,204,788,000 after purchasing an additional 2,115,814 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its position in shares of Intuitive Surgical by 1,043.3% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 1,342,121 shares of the medical equipment provider’s stock worth $760,124,000 after buying an additional 1,224,734 shares during the period. Polen Capital Management LLC acquired a new stake in shares of Intuitive Surgical in the fourth quarter worth $477,225,000. Finally, Assenagon Asset Management S.A. grew its holdings in shares of Intuitive Surgical by 106.6% during the fourth quarter. Assenagon Asset Management S.A. now owns 1,533,771 shares of the medical equipment provider’s stock valued at $868,667,000 after buying an additional 791,516 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Trending Headlines about Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

Positive Sentiment: Intuitive Surgical reported stronger-than-expected Q2 revenue and earnings, helped by solid demand for its da Vinci robotic surgery systems and continued adoption of its products. Reuters article
Positive Sentiment: The company still reported healthy procedure growth overall, with worldwide procedures rising and placements of robotic systems remaining strong, which supports the long-term investment case. Yahoo Finance article
Neutral Sentiment: Several analysts lowered price targets after the report, but most kept bullish ratings such as overweight, buy, or outperform, suggesting Wall Street still sees meaningful upside despite the near-term pullback. Benzinga article
Negative Sentiment: Management did not raise its forecast for procedure growth, and investors reacted badly to slower U.S. procedure growth and a cautious full-year outlook. Benzinga article
Negative Sentiment: Reuters also noted concerns that changes to some insurance plans could reduce demand, adding to worries about slower U.S. growth and a softer near-term procedure trajectory. Reuters article

Insider Activity

In related news, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Wednesday, June 10th. The stock was sold at an average price of $424.14, for a total value of $169,656.00. Following the transaction, the executive vice president owned 5,720 shares in the company, valued at approximately $2,426,080.80. This represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Iman Jeddi sold 5,625 shares of the firm’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total transaction of $2,365,593.75. Following the transaction, the senior vice president directly owned 6,463 shares in the company, valued at approximately $2,718,014.65. The trade was a 46.53% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,169 shares of company stock worth $3,059,135 in the last three months. 0.60% of the stock is owned by insiders.

Analysts Set New Price Targets

Several research analysts recently weighed in on ISRG shares. Royal Bank Of Canada dropped their price target on Intuitive Surgical from $650.00 to $600.00 and set an “outperform” rating on the stock in a research report on Monday, July 13th. Wall Street Zen upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, June 13th. Barclays set a $651.00 target price on Intuitive Surgical and gave the company an “overweight” rating in a research note on Thursday, April 23rd. Leerink Partners dropped their target price on Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating on the stock in a report on Friday. Finally, HSBC reduced their price target on shares of Intuitive Surgical from $653.00 to $604.00 and set a “buy” rating for the company in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, twenty have assigned a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $523.46.

Read Our Latest Research Report on ISRG

Intuitive Surgical Stock Performance

Shares of NASDAQ:ISRG opened at $345.42 on Monday. The firm has a market cap of $122.33 billion, a price-to-earnings ratio of 39.57, a P/E/G ratio of 2.80 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $344.55 and a 1 year high of $603.88. The business has a fifty day simple moving average of $415.28 and a 200 day simple moving average of $467.12.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last issued its earnings results on Tuesday, April 21st. The medical equipment provider reported $2.50 EPS for the quarter, beating analysts’ consensus estimates of $2.08 by $0.42. Intuitive Surgical had a return on equity of 17.09% and a net margin of 28.45%.The firm had revenue of $2.77 billion for the quarter, compared to the consensus estimate of $2.62 billion. During the same quarter in the previous year, the company posted $1.81 earnings per share. The business’s quarterly revenue was up 23.0% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 8.62 EPS for the current year.

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.